Mayran Nathalie, Parton Robert G, Gruenberg Jean
Department of Biochemistry, University of Geneva, 30 quai E Ansermet, 1211 Geneva 4, Switzerland.
EMBO J. 2003 Jul 1;22(13):3242-53. doi: 10.1093/emboj/cdg321.
Proteins of the annexin family are believed to be involved in membrane-related processes, but their precise functions remain unclear. Here, we have made use of several experimental approaches, including pathological conditions, RNA interference and in vitro transport assays, to study the function of annexin II in the endocytic pathway. We find that annexin II is required for the biogenesis of multivesicular transport intermediates destined for late endosomes, by regulating budding from early endosomes-but not the membrane invagination process. Hence, the protein appears to be a necessary component of the machinery controlling endosomal membrane dynamics and multivesicular endosome biogenesis. We also find that annexin II interacts with cholesterol and that its subcellular distribution is modulated by the subcellular distribution of cholesterol, including in cells from patients with the cholesterol-storage disorder Niemann-Pick C. We conclude that annexin II forms cholesterol-containing platforms on early endosomal membranes, and that these platforms regulate the onset of the degradation pathway in animal cells.
膜联蛋白家族的蛋白质被认为参与与膜相关的过程,但其确切功能仍不清楚。在这里,我们利用了几种实验方法,包括病理状况、RNA干扰和体外转运分析,来研究膜联蛋白II在内吞途径中的功能。我们发现,膜联蛋白II通过调节从早期内体出芽——而不是膜内陷过程,是注定要进入晚期内体的多泡转运中间体生物发生所必需的。因此,该蛋白质似乎是控制内体膜动力学和多泡内体生物发生机制的必要组成部分。我们还发现膜联蛋白II与胆固醇相互作用,其亚细胞分布受胆固醇亚细胞分布的调节,包括在患有胆固醇储存障碍尼曼-皮克病C型患者的细胞中。我们得出结论,膜联蛋白II在早期内体膜上形成含胆固醇的平台,并且这些平台调节动物细胞中降解途径的起始。